Cited by 173Schizophrenia research and treatmentGlobal Cancer Incidence and ScreeningSuicide and Self-Harm Studies

Cancer mortality in patients with schizophrenia: An 11‐year prospective cohort study

Tran, Eric, Rouillon, Frédéric, Loze, Jean‐Yves, Casadebaig, Françoise, Philippe, Alain, Vitry, Fabien, Limosin, Frédéric·2009·Cancer

Abstract

BACKGROUND: Schizophrenia has been associated with a rate of premature mortality that is 2 to 3 times higher than that in the general population. Although the role of cancer in this excess mortality remains unclear, previous incidence or mortality studies found contradictory results. METHODS: In 1993, a large prospective study was initiated in a cohort of 3470 patients with schizophrenia to examine cancer‐related mortality and predictors. Standardized mortality ratios (SMRs) were calculated, adjusting for age and sex relative to a representative sample of the French general population. RESULTS: During the 11‐year follow‐up, 476 (14%) patients died; the mortality rate was thus nearly 4‐fold higher than in the general population. Cancer was the second most frequent cause of mortality (n = 74), with a global SMR of 1.5 (95% confidence interval [95% CI], 1.2‐1.9). For all cancers, the SMRs were 1.4 (not significant) for men and 1.9 (95% CI, 1.4‐2.8) for women. For men, lung cancer was the most frequent localization (n = 23; 50%), with an SMR of 2.2 (95% CI, 1.6‐3.3). For women, breast cancer was the most frequent localization (n = 11; 39%), with an SMR of 2.8 (95% CI, 1.6‐4.9). In comparison with patients who did not die of cancer, there were 2 significant baseline predictors of death by lung cancer in the final logistic regression model: duration of smoking and age >38 years. CONCLUSIONS: The results of the current study demonstrated an increased risk of mortality by cancer in patients with schizophrenia, especially for women from breast cancer and for men from lung cancer. Cancer 2009. © 2009 American Cancer Society.

Integrity signals

Registry

Crossref · 10.1002/cncr.24383

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 33 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Tran, E., Rouillon, F., Loze, J., Casadebaig, F., Philippe, A., Vitry, F., & Limosin, F.
Affiliations
  • Université de Reims Champagne-Ardenne (FR)
  • Université Paris Cité (FR)
  • Inserm (FR)
Venue
Cancer
Publisher
Wiley
Published
2009-06-22
Volume
115
Issue
15
Pages
3555-3562
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2021564981
Cited by
173
References
33
Citations by year
2026: 6 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 15 · 2018: 14 · 2017: 12 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 20 · 2012: 15
FWCI
8.43
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
Keywords
schizophrenia, cancer mortality, premature mortality, lung cancer, breast cancer, sex differences, smoking duration, standardized mortality ratio, mortality risk factors
MeSH terms
Adolescent, Adult, Breast Neoplasms, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasms, Schizophrenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review